Illumina | ILMN - Ordinary Share Capital


Illumina reported $151.3M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Agilent USD 282.22M 478K Mar/2026
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
Bruker USD 152.35M 130K Jun/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Danaher USD 702.9M 4.8M Jun/2026
Dentsply International USD 199.2M 1.1M Jun/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
Illumina USD 151.3M 607K Jun/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Laboratory Of America USD 80.9M 1.4M Jun/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quest Diagnostics USD 110M 1000K Jun/2026
Quidel USD 68.1M 200K Mar/2026
Repligen USD 56.43M 28K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Standard Biotools USD 390.14M 3.76M Mar/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Waters USD 98.19M 20K Jun/2026